Korean Drug Co., Ltd. (KOSDAQ:014570)
4,160.00
+55.00 (1.34%)
At close: Jan 23, 2026
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 45.39 billion as of January 23, 2026. Its market cap has decreased by -11.68% in one year.
Market Cap
45.39B
Enterprise Value
16.44B
Revenue
62.21B
Ranking
n/a
PE Ratio
16.26
Stock Price
4,160.00
Market Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 45.39B, an increase of 261.99%. That is a compound annual growth rate of 6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 45.39B | -3.26% |
| Dec 30, 2025 | 46.92B | -6.42% |
| Dec 30, 2024 | 50.14B | -36.00% |
| Dec 28, 2023 | 78.35B | -8.30% |
| Dec 29, 2022 | 85.44B | -12.32% |
| Dec 30, 2021 | 97.44B | -13.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Optipharm.CO.,LTD | 73.35B |
| Sinil Pharmaceutical | 66.89B |
| Cosmax Nbt | 64.13B |
| Jin Yang Pharmaceutical | 62.49B |
| Korea Arlico Pharm | 62.46B |
| RP Bio | 55.81B |
| Eagle Veterinary Technology Co.,Ltd | 52.72B |
| Kyung Nam Pharm | 47.44B |